S100A4 and myeloid sarcoma: Immunohistochemical analysis of WM from non-neurological controls showed weak vascular SNAI1 and FSP1 protein expression (Fig. 5a, b), whereas both proteins were strongly expressed in MS patients (Fig. 5c–n), with significantly increased expression levels in chronic active lesions (Fig. 5o, p).